Virios Therapeutics, Inc. Quarterly Return On Assets in % from Q3 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Virios Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2021 to Q2 2024.
  • Virios Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -115 %, a 17.5% decline year-over-year.
  • Virios Therapeutics, Inc. annual Return On Assets for 2023 was -100 %, a 16.5% increase from 2022.
  • Virios Therapeutics, Inc. annual Return On Assets for 2022 was -120 %, a 65.3% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -115 -17.1 -17.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 -114 -0.89 -0.79% Jan 1, 2024 Mar 31, 2024
Q4 2023 -100 +19.9 +16.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -98.4 +23.6 +19.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -97.9 +15.2 +13.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -113 -19.3 -20.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -120 -47.4 -65.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -122 -52.8 -76.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -113 Apr 1, 2022 Jun 30, 2022
Q1 2022 -93.4 Jan 1, 2022 Mar 31, 2022
Q4 2021 -72.6 Oct 1, 2021 Dec 31, 2021
Q3 2021 -69.3 Jul 1, 2021 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.